Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acoustic neurinoma
acoustic neurinoma, bilateral
acquired immunodeficiency syndrome
adrenoleukodystrophy
advances in neurology
adverse drug reaction
Alexanders disease
algorithm
Alzheimer's disease
Alzheimer's disease, familial
amniocentesis
amyloid angiopathy, cerebral
amyloid angiopathy, hereditary cystatin C
attention deficit disorder with hyperactivity
audiogram
auditory evoked brainstem potentials
basal ganglia, degeneration
basal ganglia, lesion of
Bassen-Kornzweig syndrome
brain biopsy
brainstem, lesion of
bulbar palsy, progressive
calcification, intracranial
CAT scan, emission
CAT scan, emission, abnormal
cataracts
cerebellar lesion
cerebro hepato renal syndrome
cerebrovascular accident
cerebrovascular accident, familial occurrence
cerebrovascular accident, young adult
Charcot-Marie-Tooth
children
chromosomal abnormality
chromosome 17
chromosome 22
chromosome 9
Cockayne's syndrome
cost effectiveness
creatine phosphokinase(CPK)elevated
cryptococcal meningitis
cytomegalovirus infection
dentate nuclei
dentate nuclei, lesion of
DNA probes
drug induced neurologic disorders
dystonia
dystonia musculorum deformens
dystrophin
ear, abnormal
electronystagmography
electroretinograph
encephalitis
encephalitis, focal
encephalitis, Rasmussen's
encephalitis, viral
enzyme, muscle disease
ependymoma
face, elongated
facial appearance, abnormal
familial
fasciculation
fragile-X syndrome
fundus, abnormality of
gadolinium
gene
gene mutation
genetic counselling
genetic diagnosis, prenatal
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
gynecomastia
Hallervorden Spatz disease
hearing loss
hemiparesis
hepatolenticular degeneration(Wilson's disease)
Huntington's chorea
Huntington's chorea, genetic counselling
Huntington's chorea, late onset
Huntington's chorea, presymptomatic detection of
Huntington's disease, children
hyperactivity
imbalance
immunohistochemistry
immunoperoxidase staining
in situ hybridization
inclusion bodies, intracytopasmic
intracerebral hemorrhage
intracerebral hemorrhage, familial
intracerebral hemorrhage, young adult
joint hypermobility
Kearns-Sayre syndrome
Kugelberg-Welander syndrome
Laurence-Moon-Bardet-Biedl syndrome
leukodystrophy
leukoencephalopathy
macular degeneration
manic-depressive
meningioma
meningitis
meningitis, recurrent
meningitis, relapse
mental retardation
mental retardation, familial
misdiagnosis
molecular genetics
mongolism
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
mucopolysaccharidoses
muscle biopsy
muscular dystrophy
muscular dystrophy, Becker
muscular dystrophy, differential diagnosis of
muscular dystrophy, Duchenne
muscular dystrophy, Duchenne, carrier
muscular dystrophy, Duchenne, neonatal screening
muscular dystrophy, Duchenne, presymptomatic detection
muscular dystrophy, female occurrence of
muscular dystrophy, limb-girdle
myopathy, mitochondrial
myopia
myotonia dystrophica
neonatal screening, genetic neurologic disorders
neoplasm, intracranial
neoplasm, intracranial, multiple
neoplasm, primary of CNS
neoplasm, primary of CNS-multiple
nerve growth factor
neurofibromatosis 1
neurofibromatosis 2
neurofibromatosis 2, presymptomatic
neurologic disease
neurologic disease, diagnoses of
neuronal ceroid-lipofuscinosis
neuropathology
neuropathy
neuropathy, amyloid
neuropathy, hereditary peripheral
neuropathy, peripheral
neurotransmitter
night blindness
optic atrophy
optic nerve
optic neuropathy
patient information and support
peptides, brain
peroxisomal disease
pigmentary retinopathy
polymerase chain reaction
polyneuropathy, familial
posterior fossa, lesion of
pregnancy, neurologic complications in
prenatal diagnosis by amniocentesis
prognosis
progressive multifocal leucoencephalopathy
progressive spinal muscular atrophy
psychological testing
psychological testing, neurologic problems
recombinant DNA
recurrent
refractive errors
Refsum's disease
retinal degeneration
retinal lesion
retinitis pigmentosa
retinopathy
review article
RFLPs
Rosenthal fibers
seizure
seizure, focal
seizure, intractable, treatment of
sensorineural hearing loss
simian crease
somatostatin
Southern immunoblot test
spinal muscular atrophy
spinocerebellar degeneration
tapetoretinal degeneration
testicular enlargement
tinnitus
treatment of neurologic disorder
Usher's syndrome
viral infection
viral infection, CNS
visual field defect
visual loss
visuospatial disturbance
Von Hippel Lindau
Von Hippel Lindau, carrier
Von Hippel Lindau, screening protocol for
Western immunoblot test
white matter disease
Wood's light
X-linked bulbospinal neuronopathy
X-linked neuropathy
Showing articles 300 to 350 of 885 << Previous Next >>

Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients
Stroke 40:2611-2612,2615, Moonis,M., 2009

Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients? No
Stroke 40:2613-2614,2615, Lindley,R.I., 2009

Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009

Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis
Stroke 40:2438-2441, Lansberg,M.G.,et al, 2009

Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Stroke 40:2594-2600, Saver,J.L.,et al, 2009

Transcranial Ultrasound in Clinical Sonothrombolysis (TUCSON) Trial
Ann Neurol 66:28-38, Molina,C.A.,et al, 2009

Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
Stroke 40:3547-3551, Rizos,T.,et al, 2009

Intraventricular Fibrinolysis and Lumbar Drainage for Ventricular Hemorrhage
Stroke 40:3275-3280, Staykov,D.,et al, 2009

Use of MRI to Estimate the Therapeutic Window in Acute Stroke: Is Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch an EPITHET for Salvageable Ischemic Brain Tissue?
Stroke 40:333-335, Toth,G. &Albers,G.W., 2009

Thrombolytic Therapy for Patients Who Wake-Up With Stroke
Stroke 40:827-832, Barreto,A.D.,et al, 2009

Thrombolysis in Childhood Stroke: Report of 2 Cases and Review of the Literature
Stroke 40:801-807, Arnold,M.,et al, 2009

Can a Subset of Intracerebral Hemorrhage Patients Benefit from Hemostatic Therapy with Recombinant Activated Factor VII?
Stroke 40:833-840, Mayer,S.A.,et al, 2009

Disappearing Hyperdense Middle Cerebral Artery Sign in Ischaemic Stroke Patients Treated with Intravenous Thrombolysis: Clinical Course and Prognostic Significance
JNNP 80:273-278,248, Kharitonova,T.,et al, 2009

The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009

Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis
Stroke 40:1710-1720, Earnshaw,S.R.,et al, 2009

Identifying Patients at High Risk for Poor Outcomes After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke 40:1780-1785, Hallevi,H.,et al, 2009

Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease
NEJM 360:1729-1739, Hara,K.,et al, 2009

Telemedicine Versus Telephone for Remote Emergency Stroke Consultations: A Critically Appraised Topic
The Neurologist 15:163-166, Capampngan,D.J.,et al, 2009

Thrombolysis in Young Adults with Ischemic Stroke
Stroke 40:2085-2091, Putaala,J.,et al, 2009

4.5 Hours: The New Time Window for Tissue Plasminogen Activator in Stroke
Stroke 40:2266-2267, Davis,S.M. &Donnan,G.A., 2009

Expansion of the Time Window for Treatment of Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator: A Science Advisory from the American Heart Association/American Stroke Association
Stroke 40:2945-2948, del Zoppo,G.J.,et al, 2009

MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009

Intravenous Thrombolysis in Stroke Attributable to Cervical Artery Dissection
Stroke 40:37772-3776, Engelter,S.,et al, 2009

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009

Ischemic Stroke and ICU Care
Semin Neurol 28:645-656, Llinas, R, 2008

Review of Tissue Plasminogen Activator, Ischemic Stroke, and Potential Legal Issues
Arch Neurol 65:1429-1433, Liang,B.A.,et al, 2008

A Case of Cocaine-Induced Basilar Artery Thrombosis
Nat Clin Pract Neurol 4:622-626, MacEwen,C., et al, 2008

Rapid Assessment of Perfusion-Diffusion Mismatch
Stroke 39:75-81, Butcher,K.,et al, 2008

Influence of the Stroke Code Activation Source on the Outcome of Acute Ischemic Stroke Patients
Neurol 70:1238-1243,1232, P�rez de la Ossa,N.,et al, 2008

Is it Time for Neurohospitalists?
Neurol 70:1282-1288, Freeman,W.D.,et al, 2008

Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
Stroke 39:850-856, Diringer,M.N.,et al, 2008

Endovascular Thrombectomy and Thrombolysis for Severe Cerebral Sinus Thrombosis: A Prospective Study
Stroke 39:1487-1490, Stam,J.,et al, 2008

Sonothrombolysis With Transcranial Color-Coded Sonography and Recombinant Tissue-Type Plasminogen Activator in Acute Middle Cerebral Artery Main Stem Occlusion: Results From a Randomized Study
Stroke 39:1470-1475,1404, Eggers,J.,et al, 2008

Intra-Arterial Thrombolysis of Acute Iatrogenic Intracranial Arterial Occlusion Attributable to Neuroendovascular Procedures or Coronary Angiography
Stroke 39:1491-1495, Arnold,M.,et al, 2008

Local Intraarterial Fibrinolysis Administered in Aliquots for the Treatment of Central Retinal Artery Occlusion: The Johns Hopkins Hospital Experience
Stroke 39:1746-1750, Aldrich,E.M.,et al, 2008

Neuroimaging in Acute Posterior Cerebral Artery Infarction
The Neurologist 14:170-180, Finelli,P.F., 2008

Stroke
Lancet 371:1612-1623, Donnan,G.A.,et al, 2008

Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke
Arch Neurol 65:607-611,575, Uyttenboogaart,M.,et al, 2008

Treatment of Childhood Arterial Ischemic Stroke
Ann Neurol 63:679-696, Bernard,T.J.,et al, 2008

Iatrogenic Arterial Perforation During Acute Stroke Interventions
AJNR 29:974-975, Nguyen,T.N.,et al, 2008

Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 358:2127-2137,2174, Mayer,S.A.,et al, 2008

Thrombolysis in Patients With Marked Clinical Fluctuations in Neurologic Status Due to Cerebral Ischemia
Arch Neurol 65:1041-1043,1017, Ozdemir,O.,et al., 2008

MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases
AJRN 29:1314-1316, Iosif,C.,et al., 2008

Prognostic Significance of Blood Pressure Variability After Thrombolysis in Acute Stroke
Neurol 71:552-558, Delgado-Mederos,R.,et al., 2008

Treatment of Cervical Artery Dissection: A Systematic Review and Meta-Analysis
JNNP 79:11222-1127, Menon,R.,et al, 2008

Thrombolysis with Alteplase 3-4.5 h After Ischaemic Stroke (SITS-ISTR): An Observational Study
Lancet 372:1303-1309, Wahlgren,N.,et al, 2008

Thrombolysis with Alteplase 3 to 4.5 Hours After Acute Ischemic Stroke
NEJM 359:1317-1329,1393, Hacke,W.,et al, 2008

Symptomatic Intracerebral Hemorrhage and Recanalization After IV rt-PA: A Multicenter Study
Neurol 71:1304-1312, Saqqur,M.,et al, 2008

Artery of Percheron Thrombolysis
AJNR 28:870-871, Kostanian,V. &Cramer,S.C., 2007

Guidelines for the Early Management of Adults With Ischemic Stroke
Stroke 38:1655-1711, Adams,H.P.,et al, 2007



Showing articles 300 to 350 of 885 << Previous Next >>